Keyron was founded by Giorgio Castagneto Gissey in 2016.

Who are Keyron's investors?

Keyron's investors include Health Wildcatters.

Keyron

Founded 2016 · 8 employees on LinkedIn · 1 known investors

Find your way into Keyron

317 people in our graph share verified history with the Keyron team — schools, employers, funds. One of them is your warm intro.

Mariaunlockedknows Giorgio Castagneto Gissey · together at University of Warwick (overlapped)

×9knows the team · via Imperial College London

×2knows the team · via UCL

Keyron develops ForePass, a fully endoscopic, non-invasive and reversible gastric bypass medical device intended to reproduce the effects of metabolic surgery for patients with Class II & III obesity, type 2 diabetes, MASH/NASH, and liver fibrosis. The company targets severe "diabesity" patients who refuse surgery or do not achieve results with drugs, across the US and EU5 markets.

Biotech Hardware Medical Devices

Founders & leadership

Keyron was founded in 2016 by Giorgio Castagneto Gissey.

Giorgio Castagneto Gissey inChief Executive, Chairman & Co-FounderDr Giorgio Castagneto Gissey is CEO and co-founder of Keyron, which develops an endoscopic gastric bypass device. He previously founded Metadeq, which developed a diagnostic for liver fibrosis, and GHP Scientific and Jemyll; he also held research and teaching positions at Imperial College and UCL, and holds a Ph.D. in Financial Economics from Imperial College Business School and an M.Sc. in Economics from the University of Warwick.

Joyce PeetermansActing CTO

David FeigalHead of Regulatory Affairs & Board Member

Francesco RubinoChief Officer for Obesity and Diabetes & Board Member

Carel le RouxChief Medical Officer & Director of Pharmaceutical Division

Nicol VerheemChief Investment Officer, Director of Diagnostics Division & Board Member

Marco CastagnetoChief Scientific Officer & Director of Medical Device Division

Board

Geltrude MingroneChief Advisor

Investors · 1

Health WildcattersDallas

Competitors · 1

by search overlap

Kairon Health3 shared keywordsKairon Health offers a data platform for value-based care that ingests claims, clinical records, and qualitative data to run healthcare workflows including field team prep, care management, HCC coding, quality gap closure, and patient outreach. It serves provider organizations and their practices with tools for practice enablement, care operations, AI-driven patient activation, and impact analytics tied to billed visits.

Companies competing with Keyron for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Raiders sign third-round pick DE Keyron Crawfordraiders.com · Jun 2026

Keyron appoints new Chief Executive Officer - BioSpacebiospace.com · Feb 2023

Investors - Keyronkeyron.com · Mar 2022

Frequently asked questions

What does Keyron do?: Keyron develops ForePass, a fully endoscopic, non-invasive and reversible gastric bypass medical device intended to reproduce the effects of metabolic surgery for patients with Class II & III obesity, type 2 diabetes, MASH/NASH, and liver fibrosis. The company targets severe "diabesity" patients who refuse surgery or do not achieve results with drugs, across the US and EU5 markets.
Who founded Keyron?: Keyron was founded by Giorgio Castagneto Gissey in 2016.
Who are Keyron's investors?: Keyron's investors include Health Wildcatters.